Clinical Trials Browser

Interventional × Advanced or Recurrent Solid Tumors × vadimezan × Clear all

NCT01285453 2020-12-09

Safety and Tolerability of ASA404 Administered in Combination With Docetaxel in Japanese Patients With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Advanced or Recurrent Solid Tumors